Research ArticleOriginal Research

A Double-Blind Randomized Controlled Trial Comparing Epidural Clonidine vs Bupivacaine for Pain Control During and After Lower Abdominal Surgery

Alaa A. Abd-Elsayed, Maged Guirguis, Mark S. DeWood and Sherif S. Zaky
Ochsner Journal June 2015, 15 (2) 133-142;

Abstract

Background Alpha-2 adrenergic agonists produce safe and effective analgesia, but most investigations studying the analgesic effect of alpha-2 adrenoceptor agonists postoperatively included previous or concomitant administration of other analgesics. Because clonidine potentiates the effect of these drugs, its own intrinsic analgesic effect has been difficult to establish. This study was designed to compare the intraoperative and postoperative effects of epidural clonidine vs bupivacaine for patients undergoing lower abdominal surgery.

Methods This randomized controlled trial included 40 patients aged 18-50 who were scheduled for elective lower abdominal surgery. Patients were randomly divided into 2 groups. Group I (n=20) received epidural clonidine; Group II (n=20) received epidural bupivacaine. Intraoperative and postoperative hemodynamics, pain scores, and complications were monitored.

Results Mean pain scores were significantly lower in Group I compared to Group II (1.5 ± 0.5 compared to 3.4 ± 1.0, respectively) in the first 12 hours after surgery. Sedation was more prominent in Group I until 9 hours after surgery. Opioid requirements were significantly lower in Group I. Respiratory rate was similar in the 2 groups. Group I had larger decreases from baseline in systolic blood pressure and diastolic blood pressure than Group II. Heart rate in Group I was reduced from baseline, while it was increased in Group II. Less postoperative nausea and vomiting, urinary retention, pruritus, and shivering were observed in Group I.

Conclusion Compared to bupivacaine, epidural clonidine provided effective intraoperative and postoperative analgesia in selected patients, resulting in a decreased intravenous pain medication requirement and prolonged duration of analgesia after epidural infusion was discontinued.

Keywords

INTRODUCTION

Alpha-2 adrenergic mechanisms of analgesia have been exploited for more than 100 years. Cocaine, the first spinal anesthetic, produces analgesia primarily by its local anesthetic action. Cocaine is also known to inhibit norepinephrine reuptake, and spinal cocaine produces analgesia, in part, by enhancing noradrenergic stimulation of alpha-2 adrenoceptors.1

Near the turn of the previous century, epinephrine was shown to produce spinal analgesia in animals, an effect now recognized to be secondary to the alpha-2 adrenoceptor. Nearly 50 years ago, spinal epinephrine alone was shown to produce clinically useful analgesia, although it is most commonly combined with local anesthetics for this purpose.2,3

Veterinarians have used alpha-2 adrenergic agonists (xylazine, detomidine, medetomidine) for many years for regional analgesia, but experience with these agents in humans dates back only 3 decades. In 1984, Tamsen and Gordh, after testing for neurotoxicity in animals, injected a parenteral preparation of the alpha-2 adrenergic agonist clonidine epidurally in 2 patients with chronic pain.4 Since then, a complete toxicologic assessment has suggested that clonidine is safe for intraspinal use.5-20

Most of the investigations studying the analgesic effect of alpha-2 adrenoceptor agonists postoperation included previous or concomitant administration of other analgesic drugs such as local anesthetics or opioids. Because clonidine has been shown to potentiate the analgesic effect of these drugs, the importance of its own intrinsic analgesic effect has remained difficult to establish.21 Two studies reported the efficacy of intrathecal clonidine as a sole analgesic agent and showed complete and long-lasting analgesia after a single intrathecal injection of clonidine in women recovering from cesarean deliveries performed without perioperative administration of additional analgesics.22,23

Our study compared the analgesic effect of defined-dose epidural clonidine as a sole epidural analgesic agent vs the more commonly used drug bupivacaine during and after lower abdominal surgery. We also compared the 2 groups with regard to hemodynamic changes, effects on respiratory function, sedative effects, and side effects.

METHODS

Study Design

This randomized, double-blind, prospective clinical trial enrolled 40 patients presenting for elective lower abdominal surgery at a tertiary care university hospital. The study was approved by the institutional review board. Sixty-two patients who fulfilled the inclusion criteria were approached. Forty-six patients agreed to participate. Six patients were excluded because of concomitant beta blocker therapy (3 patients), abnormal coagulation profile (2 patients), and cardiac conduction defect (1 patient) (Figure). After providing informed consent, patients were randomly divided into 2 groups of 20 patients each. Randomization was done using sealed and shuffled envelopes with treatment allocations inside. Each envelope was opened by an investigator just before surgery to learn the group assignment and to order the infusion. All patients were treated strictly as randomly assigned.

Figure.
Figure.

Study flowchart.

Outcomes

The primary outcome was the comparison of pain control between groups. Secondary outcomes were the comparisons of hemodynamic changes, effects on respiratory function, sedative effects, and side effects between the two groups.

Participants

All patients were 18-50 years of age, American Society of Anesthesiologists (ASA) physical status category 1 or 2, and scheduled for elective lower abdominal surgery (ie, oblique inguinal hernia, femoral hernia, lower abdominal incisional hernia repairs, and abdominal hysterectomy) at a tertiary care university hospital in Cairo, Egypt.

Exclusion criteria were any history of allergy to the drugs used in the study, abnormal coagulation profiles, abnormal hepatic or renal function, chronic pain, cardiac conduction defects, or use of beta blocker therapy.

Blinding

All patients were blinded to the treatments used. Physicians who took care of the patients intraoperatively and postoperatively, including investigators who collected the postoperative outcomes of interest, were blinded to the treatments used. In addition, the biostatistician who performed the statistical analysis was blinded. Groups were labeled as Group I (patients who received epidural clonidine) and Group II (patients who received epidural bupivacaine). All previously mentioned participants were unaware of the treatment assigned to Group I as well as Group II.

Preoperative

All patients received intravenous (IV) premedication with midazolam 0.05 mg/kg 30 minutes before induction.

Intraoperative

Monitors were applied after establishing an IV line and infusing 1 L of crystalloid solution; in the operating room, an epidural catheter was inserted in all patients at the L2-L3 vertebral interspace. Level identification was done using anatomic landmarks with the line across the highest points of the iliac crests (Tuffier's line) used to identify the L4 vertebral body or the L4-L5 interspace. The epidural space was identified using the midline approach with loss of resistance to air. An epidural catheter was then inserted 4 cm past the needle tip.

Patients in Group I (n=20) received an initial dose of epidural clonidine of 10 μg/kg in 7 mL saline in 15 minutes, followed immediately by an infusion of 6 μg/kg/h (7 mL/h). Patients in Group II (n=20) received an initial dose of bupivacaine 0.5% in 7 mL saline (=35 mg) in 15 minutes, followed immediately by an infusion of bupivacaine 0.25% (7 mL/h=17.5 mg/h). Epidural infusion at the stated doses was maintained in both groups during the first 12 postoperative hours.

In all patients, general anesthesia was induced concomitantly with the epidural infusion. Induction of anesthesia was performed using thiopental sodium (3-5 mg/kg), and tracheal intubation was facilitated by atracurium (0.5 mg/kg). An IV bolus of lidocaine was given 1 minute before intubation. Additional bolus doses of fentanyl (0.5 μg/kg) were given to patients who had an increase of 20% in mean arterial blood pressure or heart rate compared to the baseline recorded after the initial dose of epidural drugs and before skin incision.

During anesthesia, the following observations were made every 30 minutes: hemodynamic data, including arterial blood pressure and heart rate; the number and dose of fentanyl injections per patient; and the occurrence of side effects. Hypotension was treated with IV ephedrine in 5 mg increments, while bradycardia was treated with atropine 0.5 mg IV until the condition resolved.

Postoperative

After reversal of muscle relaxation and tracheal extubation, patients were transferred to the postanesthesia care unit where they were assessed hourly for 12 postoperative hours for the following parameters.

  • 1.  Hemodynamic monitoring consisted of heart rate, systolic arterial blood pressure (SBP), and diastolic arterial blood pressure (DBP) measurements. Hypotension and bradycardia were defined as a decrease of ≥20% from baseline.

  • 2.  Respiratory rate and arterial oxygen saturation were measured with pulse oximetry.

  • 3.  Degree of pain was assessed using the visual analog scale (VAS), a 0-10 scale with 0=no pain and 10=maximum intolerable pain.24,25 In cases of VAS scores ≥5 at rest or ≥8 with coughing, a registered nurse administered 1.5 mg IV morphine as needed with a lockout time of 10 minutes and a maximum dose of 10 mg/h. Duration of analgesia was measured as the time to the first requirement of IV analgesia after discontinuation of the epidural infusion at the end of the initial 12 postoperative hours.

  • 4.  Postoperative side effects such as nausea, vomiting, urinary retention, pruritus, and shivering were recorded.

  • 5.  Opioid requirements were measured as the number of intraoperative fentanyl boluses and the number of postoperative morphine injections per patient.

  • 6.  Degree of sedation was assessed using the Ramsay sedation scale, a 0-3 scale with 0=alert or drowsy, easily roused by verbal command; 1=sleepy, but roused by verbal command; 2=sleepy, but roused by tactile stimulation; and 3=sleepy, and not roused by tactile stimulation.26

Statistical Analysis

Continuous data were presented in the form of mean ± standard deviation or median and range. Categorical data were presented in the form of number and percentage. Two independent sample group comparisons of continuous data parameters were performed by using the Mann-Whitney U test. Paired comparison within the same group was performed by using the Wilcoxon rank-sum test. Between groups, comparisons of categorical data parameters were performed by using the chi-square test or the Fisher exact test (x2 value). Sample size was calculated based on 85% power of analysis, and P value was considered significant if <0.05.

RESULTS

Demographics

The 2 groups had no significant differences with respect to age, sex, weight, and duration of anesthesia (P>0.05) (Table 1).

View this table:
Table 1.

Demographic Data of Enrolled Patients

Pain

Pain scores measured using the VAS during rest were significantly lower in Group I than in Group II (mean of 1.5 ± 0.5 compared to 3.4 ± 1.0, respectively) during the first 12 postoperative hours (Table 2). Patients who received epidural clonidine did not require any intraoperative boluses of IV fentanyl; however, patients who received epidural bupivacaine required 1-2 doses of fentanyl 50 μg (median, 1 dose).

View this table:
Table 2.

Pain Scores According to the Visual Analog Scale (VAS)

During the postoperative period, patients on epidural clonidine (Group I) did not require any rescue medication for pain, while patients on epidural bupivacaine (Group II) required 2-4 doses of 1.5 mg morphine sulfate each during the first 12 postoperative hours (median, 3 doses; P<0.001).

Postoperative Analgesia

Clonidine produced significantly longer analgesia than bupivacaine as measured by the first requirement for analgesic medication after discontinuation of the epidural infusion. Mean duration was 297 ± 28.3 minutes in Group I vs 74.3 ± 10.4 minutes in Group II.

Intraoperative Hemodynamics

SBP during the intraoperative period significantly decreased in both groups compared to the baseline reading (Table 3). The lowest mean intraoperative SBP and DBP readings, expressed as percentage change from the baseline readings, did not show significant variation between the 2 groups. Respective SBP and DBP changes were −21.2% ± 3.9% and −13.3% ± 2.8% in Group I vs −17.1% ± 3.6% and −8.8% ± 3.1% in Group II.

View this table:
Table 3.

Blood Pressure and Heart Rate for Group I (Clonidine) and Group II (Bupivacaine)

Heart rates of patients in Group I significantly decreased by −10% ± 3.3% during the intraoperative period, while the patients in Group II showed a significant increase in heart rate by +27% ± 15.1% (Table 3).

Postoperative Hemodynamics

Intergroup comparison showed significant differences between the 2 groups in postoperative SBP and heart rate (Table 3). SBP was significantly lower than the baseline reading in Group I with a percentage change of −15.5% ± 8.7%. Group II had no significant difference in SBP compared to the baseline (−2.7% ± 8.1%) for most of the postoperative period, except that SBP was significantly higher than the baseline during the first 2 hours after recovery. For DBP, values were −10.6% ± 2.6% in Group I and −6.7% ± 3.4% in Group II.

The postoperative heart rate of patients in Group I was not significantly different from baseline (percentage change of −0.4% ± 15.8%), while patients in Group II continued to demonstrate significantly elevated heart rates (19% ± 19.6%).

Respiratory Function

Respiratory rate and hemoglobin oxygen saturation did not show significant differences between the 2 groups during the postoperative period (Table 4).

View this table:
Table 4.

Respiratory Rate (RR) and Oxygen (O2) Saturation for Group I (Clonidine) and Group II (Bupivacaine)

Postoperative Side Effects

Group I demonstrated fewer incidences of nausea, vomiting, and pruritus compared to Group II, but the differences were not significant (P>0.05). Urinary retention and shivering were significantly lower in Group I (P<0.05 and P<0.001, respectively) (Table 5).

View this table:
Table 5.

Postoperative Side Effects

Sedation

Sedation scores were significantly higher in Group I compared to Group II until 9 hours after surgery (P<0.001) (Table 6).

View this table:
Table 6.

Sedation Scores According to the Ramsay Sedation Scale

DISCUSSION

Our study was designed to compare defined-dose epidural clonidine as a sole analgesic agent vs epidural bupivacaine during and after lower abdominal surgeries.

Regarding hemodynamic effects, the present study demonstrated no significant intraoperative differences in SBP between groups. Statistically significant decreases in blood pressure were seen in both groups compared to baseline that were managed by IV fluids, but vasopressors were not needed by any patient. Clonidine resulted in significantly lower SBP compared to bupivacaine during the postoperative period, although DBP was not significantly different between groups. These results are consistent with other studies that showed bolus administration of epidural clonidine causes a dose-independent reduction in blood pressure and a 5%-20% reduction in heart rate.12,27 However, other studies demonstrate that clonidine (150-600 μg) added to epidural bupivacaine or lidocaine does not reduce blood pressure more than local anesthetic alone and does not diminish blood pressure response to ephedrine.28,29

Heart rate in Group I was significantly decreased from baseline during the intraoperative period. This effect was in contrast to the significant increase from baseline experienced by Group II. The decrease in heart rate in Group I was not associated with hemodynamic instability that necessitated intervention. It should be kept in mind that the patients involved in this study were young and were classified as ASA 1 or 2, and the surgical procedures were simple with no major fluid shift or blood loss.

In 1999, De Kock and colleagues demonstrated that epidural clonidine used as a sole agent provides dose-dependent control of the hemodynamic changes associated with surgical stimulation and dose-dependent postoperative analgesia without major side effects.30 Hemodynamic stability can be explained by clonidine's actions at different sites involved in blood pressure control. Clonidine acts at central and medullary sites to reduce blood pressure and on peripheral alpha-2 adrenergic receptors on blood vessels to cause vasoconstriction.20 Measured blood pressure is the net result of these opposing effects. Moreover, profound bradycardia is a rare complication of clonidine administration, even after a massive overdose.31

Regarding the analgesic effects in the present study, patients in Group I showed statistically significant lower pain scores and decreased opioid requirements during the postoperative periods than patients in Group II. Although systemic administration of clonidine also reduces anesthetic requirements, De Kock and colleagues demonstrated in 1993 that epidural clonidine showed a 50%-75% reduction in supplemental propofol and alfentanil use compared with the same dose of IV clonidine during surgery.32 In a study of intraoperative and postoperative analgesia, epidural clonidine appeared to be significantly more effective than bupivacaine.30 During anesthesia, epidural clonidine was particularly efficient in blunting stress responses (hypertension or tachycardia) in response to surgical incision. A purely hemodynamic effect was considered unlikely based on data obtained using the electroencephalographic bispectral index. Patients in Group I required significantly fewer propofol supplementations than patients in Group II to maintain the index in a range compatible with adequate anesthesia. Because systemic absorption of spinal clonidine is fast and significant, this anesthetic-sparing effect is possibly the result of a central hypnotic action consecutive to systemic absorption.21,33,34

An important reduction of the noxious afferent inputs to the central site, consecutive to a spinal regional effect, can influence the state of general anesthesia.35 In anesthetized patients, high-dose epidural clonidine (8 μg/kg) resulted in a greater depression of the electroencephalogram than the same dose injected via the systemic route.36 A separate study demonstrated that epidural clonidine was clearly associated with a greater reduction of intraoperative anesthetic/analgesic supplementation compared with systemic administration.37 These 2 observations argue for a specific spinal anesthetic-sparing effect of epidural clonidine.

In a double-blind, placebo-controlled trial, epidural clonidine reduced intraoperative IV fentanyl requirements by 50% and provided postoperative analgesia for 4 hours without significantly reducing blood pressure.38 Epidural clonidine increased the duration of analgesia from fentanyl more than 2-fold in patients after abdominal aortic surgery and reduced epidural fentanyl infusion requirements by 45% after colorectal surgery.39,40 The addition of epidural clonidine to sufentanil produces longer analgesia than sufentanil alone.41 In animals, spinal alpha-2 adrenergic agonists interact synergistically with the μ receptor but not all opioid receptor subtypes. This interaction may explain the lack of enhancement from the addition of epidural clonidine to butorphanol in humans.42,43

Epidural clonidine has been combined with morphine in postoperative patients in 4 double-blind controlled studies. Whereas a single bolus of 75 μg clonidine did not affect analgesia from epidural morphine after meniscectomy, larger doses (150 and 280 μg) in the same study did enhance analgesia from morphine after total hip replacement and after pancreatectomy in a separate study.44-46 In both studies with larger clonidine doses, onset of effective analgesia was more rapid with clonidine-morphine than with morphine alone. Because the time course of action differs so widely between clonidine and morphine, their interaction could more easily be investigated during continuous infusion. Motsch and colleagues demonstrated that continuous epidural clonidine infusion reduced pain scores and the use of supplemental analgesics and improved forced vital capacity when added to epidural morphine.47

Epidural clonidine combined with local anesthetics has demonstrated increased duration of postoperative analgesia, reduced pain scores, and less need for systemic rescue pain medication than bupivacaine alone without increasing the incidence of hypotension or bradycardia.48 Similarly, the addition of epidural clonidine to a postoperative infusion of bupivacaine plus morphine reduced pain during mobilization and coughing compared with bupivacaine plus morphine alone.49

When an epidural bolus of clonidine is used as a sole agent, analgesia lasting from 2-6 hours has been demonstrated with no increase in duration beyond a dose of 400 μg.44,46 Adequate analgesia has been achieved in patients who administered epidural clonidine by patient-controlled analgesia at 24 + 14 μg/h after a loading dose of 417 μg post scoliosis surgery.50 Similarly, 25 μg/h epidural clonidine was equipotent to epidural morphine (1 mg bolus plus 0.1 mg/h) in patients after total hip replacement, whereas 50 μg/h clonidine was more potent in reducing rescue analgesic requirements.45 A much larger epidural clonidine infusion rate (120-150 μg/h) provided complete analgesia in patients after major abdominal procedures.51

The results of the present study were different from those obtained by Filos and colleagues who used intrathecal clonidine as a sole agent for postoperative analgesia after cesarean delivery.52 The largest bolus dose those authors used was 450 μg (approximately 6 μg/kg) of spinal clonidine, resulting in complete postoperative analgesia lasting 864 ± 80 minutes. When clonidine is administered intrathecally, more drug is immediately available at its site of spinal action (the spinal dorsal horn). Also, in Filos et al, healthy young women with Pfannenstiel incisions were considered in the early postpartum period. Along with the evident psychological benefits of delivery, the end of pregnancy is associated with high levels of endorphins in humans.13

Regarding respiratory function, epidural clonidine used as a sole agent did not show evidence of respiratory depression even with the use of defined doses. No significant differences in respiratory rate and arterial oxygen saturation were seen in our 2 groups, consistent with previous work demonstrating that the addition of clonidine to epidural bupivacaine or lidocaine for surgery produces sedation with no change in respiratory rate or the arterial partial pressure of oxygen.28

Postoperative sedation was more prominent in Group I vs Group II in our study. Although no patient reached a sedation score of 3 during the postoperative period, most patients had a score of 2 during the immediate postoperative period. Sedation scores decreased to 1 after 2 hours, and most patients had a sedation score of 0 after the 8th hour. This finding is in agreement with the 1999 work of De Kock and colleagues who demonstrated the absence of major and long-lasting postoperative sedation after similar large doses of epidural clonidine.30 The explanation they proposed was the development of tachyphylaxis to the sedative effects of the alpha-2 adrenergic agonists, but this hypothesis remains unproven. In our study, moderate sedation was more frequent in patients who received clonidine than in patients who received bupivacaine. However, no evidence exists to indicate that this difference significantly influenced the analgesic requirements. Sedation has been documented after systemic, epidural, and intrathecal administration of clonidine in humans.22,32,52 Experimental data have shown the sedative hypnotic effect of alpha-2 adrenergic agonists is caused by action primarily on the locus coeruleus.34

Systemically administered alpha-2 adrenergic agonists have been advocated for premedication before surgery to provide sedation without respiratory depression.38 In a study of epidural clonidine premedication, Penon and associates observed intense sedation 60-120 minutes after injection in 7 patients accompanied by decreased blood pressure (by 12%-25%) and decreased heart rate (by 10%-16%).53 Although snoring was observed in 5 of 7 patients and ventilatory response to inhaled carbon dioxide was mildly depressed, clonidine did not alter end tidal carbon dioxide, and all patients had oxyhemoglobin saturation >95% without supplemental oxygen.

Our study showed no significant difference in the incidence of nausea and vomiting in the two groups. Group I had no cases of urinary retention while Group II had 5, a statistically significant difference. Pruritus occurred in 1 patient in Group II and no patients in Group I, and this difference could be explained by the higher use of morphine sulfate in Group II. Shivering occurred in 12 patients in Group II compared to no patients in Group I. The higher incidence of shivering in Group II can be explained by the sympathetic blockade effect of bupivacaine that causes cold sensation and shivering. In these circumstances, patients frequently asked for something to make them more comfortable.

These findings are supported by the work of Rosa-e-Silva and colleagues who used clonidine to treat nausea and vomiting in patients with gastroparesis and by the work done in 1999 by De Kock et al who noted the lack of major side effects after administration of a similar large dose of epidural clonidine.30,54 In the De Kock et al study, the incidence of nausea and vomiting was significantly lower in Group 1 than in Group 2 (10% vs 45%), and none of the patients on clonidine suffered shivering (compared to 65% in Group 2).

Although other studies report the use of epidural clonidine for pain control, our study is unique because it addresses a different population, confirms efficacy, and provides a detailed hemodynamic profile in the immediate postoperative period.

CONCLUSION

Clonidine can be used as a sole epidural analgesic agent in defined dose in patients classified as ASA 1 or 2 who have no contraindications for clonidine. Patients on epidural clonidine require close postoperative hemodynamic monitoring for the duration of epidural infusion and for the first few hours after stopping the infusion.

This article meets the Accreditation Council for Graduate Medical Education and the American Board of Medical Specialties Maintenance of Certification competencies for Patient Care, Medical Knowledge, and Practice-Based Learning and Improvement.

ACKNOWLEDGMENTS

The authors have no financial or proprietary interest in the subject matter of this article.

REFERENCES

  1. ↵
    1. Misra AL,
    2. Pontani RB,
    3. Vadlamani NL.
    (1, 1987) Stereospecific potentiation of opiate analgesia by cocaine: predominant role of noradrenaline. Pain 28(1):129–138, pmid:3822492.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Reddy SV,
    2. Maderdrut JL,
    3. Yaksh TL.
    (6, 1980) Spinal cord pharmacology of adrenergic agonist-mediated antinociception. J Pharmacol Exp Ther 213(3):525–533, pmid:6110767.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Collins JG,
    2. Kitahata LM,
    3. Matsumoto M,
    4. Homma E,
    5. Suzukawa M.
    (4, 1984) Spinally administered epinephrine suppresses noxiously evoked activity of WDR neurons in the dorsal horn of the spinal cord. Anesthesiology 60(4):269–275, pmid:6322616.
    OpenUrlPubMed
  4. ↵
    1. Tamsen A,
    2. Gordh T.
    (10 13, 1984) Clonidine is not neurotoxic. Lancet 2(8407):876, pmid:6148610.
    OpenUrlPubMed
  5. ↵
    1. Yaksh TL,
    2. Reddy SV.
    (6, 1981) Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. Anesthesiology 54(6):451–467, pmid:6112935.
    OpenUrlCrossRefPubMed
    1. Gordh T Jr.,
    2. Feuk U,
    3. Norlén K.
    (12, 1986) Effect of epidural clonidine on spinal cord blood flow and regional and central hemodynamics in pigs. Anesth Analg 65(12):1312–1318, pmid:3777462.
    OpenUrlPubMed
    1. Gordh T Jr.,
    2. Post C,
    3. Olsson Y.
    (12, 1986) Evaluation of the toxicity of subarachnoid clonidine, guanfacine, and a substance P-antagonist on rat spinal cord and nerve roots: light and electron microscopic observations after chronic intrathecal administration. Anesth Analg 65(12):1303–1311, pmid:2430489.
    OpenUrlPubMed
    1. Eisenach JC,
    2. Dewan DM,
    3. Rose JC,
    4. Angelo JM.
    (4, 1987) Epidural clonidine produces antinociception, but not hypotension, in sheep. Anesthesiology 66(4):496–501, pmid:3565815.
    OpenUrlCrossRefPubMed
    1. Gordh T Jr.
    (11, 1988) Epidural clonidine for treatment of postoperative pain after thoracotomy. A double-blind placebo-controlled study. Acta Anaesthesiol Scand 32(8):702–709, pmid:3063048.
    OpenUrlPubMed
    1. Eisenach JC,
    2. Castro MI,
    3. Dewan DM,
    4. Rose JC.
    (1, 1989) Epidural clonidine analgesia in obstetrics: sheep studies. Anesthesiology 70(1):51–56, pmid:2912316.
    OpenUrlPubMed
    1. Eisenach JC,
    2. Castro MI,
    3. Dewan DM,
    4. Rose JC,
    5. Grice SC.
    (2, 1989) Intravenous clonidine hydrochloride toxicity in pregnant ewes. Am J Obstet Gynecol 160(2):471–476, pmid:2916635.
    OpenUrlPubMed
  12. ↵
    1. Eisenach JC,
    2. Rauck RL,
    3. Buzzanell C,
    4. Lysak SZ.
    (11, 1989) Epidural clonidine analgesia for intractable cancer pain: phase I. Anesthesiology 71(5):647–652, pmid:2817457.
    OpenUrlPubMed
  13. ↵
    1. Eisenach JC,
    2. Dobson CE 2nd.,
    3. Inturrisi CE,
    4. Hood DD,
    5. Agner PB.
    (11, 1990) Effect of pregnancy and pain on cerebrospinal fluid immunoreactive enkephalins norepinephrine in healthy humans. Pain 43(2):149–154, pmid:2087327.
    OpenUrlPubMed
    1. Crosby G,
    2. Russo MA,
    3. Szabo MD,
    4. Davies KR.
    (12, 1990) Subarachnoid clonidine reduces spinal cord blood flow and glucose utilization in conscious rats. Anesthesiology 73(6):1179–1185, pmid:2248395.
    OpenUrlPubMed
    1. Eisenach J,
    2. Detweiler D,
    3. Hood D.
    (2, 1993) Hemodynamic and analgesic actions of epidurally administered clonidine. Anesthesiology 78(2):277–287, pmid:8439023.
    OpenUrlCrossRefPubMed
    1. Yaksh TL,
    2. Rathbun M,
    3. Jage J,
    4. Mirzai T,
    5. Grafe M,
    6. Hiles RA.
    (10, 1994) Pharmacology and toxicology of chronically infused epidural clonidine · HCl in dogs. Fundam Appl Toxicol 23(3):319–335, pmid:7835532.
    OpenUrlCrossRefPubMed
    1. Eisenach JC,
    2. D'Angelo R,
    3. Taylor C,
    4. Hood DD.
    (8, 1994) An isobolographic study of epidural clonidine and fentanyl after cesarean section. Anesth Analg 79(2):285–290, pmid:7639365.
    OpenUrlPubMed
    1. Eisenach JC,
    2. DuPen S,
    3. Dubois M,
    4. Miguel R,
    5. Allin D.
    (6, 1995) Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group. Pain 61(3):391–399, pmid:7478682.
    OpenUrlCrossRefPubMed
    1. Eisenach JC,
    2. Hood DD,
    3. Tuttle R,
    4. Shafer S,
    5. Smith T,
    6. Tong C.
    (7, 1995) Computer-controlled epidural infusion to targeted cerebrospinal fluid concentrations in humans. Clonidine. Anesthesiology 83(1):33–47, pmid:7605017.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Eisenach J,
    2. De Kock M,
    3. Klimscha W.
    (9, 1996) Alpha(2)-adrenergic agonists for regional anesthesia. A clinical review of clonidine (1984-1995). Anesthesiology 85(3):655–674, pmid:8853097.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Meert TF,
    2. De Kock M.
    (9, 1994) Potentiation of the analgesic properties of fentanyl-like opioids with alpha 2-adrenoceptor agonist in rats. Anesthesiology 81(3):677–688, pmid:7916547.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Filos KS,
    2. Goudas LC,
    3. Patroni O,
    4. Polyzou V.
    (8, 1992) Intrathecal clonidine as a sole analgesic for pain relief after cesarean section. Anesthesiology 77(2):267–274, pmid:1642346.
    OpenUrlPubMed
  23. ↵
    1. Filos KS,
    2. Goudas LC,
    3. Patroni O,
    4. Polyzou V.
    (9, 1994) Hemodynamic and analgesic profile after intrathecal clonidine in humans. A dose-response study. Anesthesiology 81(3):591–601, pmid:8092504, discussion 27A-28A.
    OpenUrlPubMed
  24. ↵
    1. DeLoach LJ,
    2. Higgins MS,
    3. Caplan AB,
    4. Stiff JL.
    (1, 1998) The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale. Anesth Analg 86(1):102–106, pmid:9428860.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Bijur PE,
    2. Silver W,
    3. Gallagher EJ.
    (12, 2001) Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med 8(12):1153–1157, pmid:11733293.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Ramsay MA,
    2. Savege TM,
    3. Simpson BR,
    4. Goodwin R.
    (6 22, 1974) Controlled sedation with alphaxalone-alphadolone. Br Med J 2(5920):656–659, pmid:4835444.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Bonnet F,
    2. Boico O,
    3. Rostaing S,
    4. et al.
    (10, 1989) Postoperative analgesia with extradural clonidine. Br J Anaesth 63(4):465–469, pmid:2684251.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Klimscha W,
    2. Chiari A,
    3. Krafft P,
    4. et al.
    (2, 1995) Hemodynamic and analgesic effects of clonidine added repetitively to continuous epidural and spinal blocks. Anesth Analg 80(2):322–327, pmid:7818120.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Klimscha W,
    2. Chiari A,
    3. Michalek-Sauberer A,
    4. et al.
    (1, 1998) The efficacy and safety of a clonidine/bupivacaine combination in caudal blockade for pediatric hernia repair. Anesth Analg 86(1):54–61, pmid:9428851.
    OpenUrlCrossRefPubMed
  30. ↵
    1. De Kock M,
    2. Gautier P,
    3. Pavlopoulou A,
    4. Jonniaux M,
    5. Lavand'homme P.
    (5, 1999) Epidural clonidine or bupivacaine as the sole analgesic agent during and after abdominal surgery: a comparative study. Anesthesiology 90(5):1354–1362, pmid:10319784, Erratum in: Anesthesiology. 1999 Aug;91(2):602.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Ciaccheri M,
    2. Dolara A,
    3. Manetti A,
    4. Botti P,
    5. Zorn M,
    6. Peruzzi S.
    (1983) A-V block by an overdose of clonidine. Acta Cardiol 38(3):233–236, pmid:6604383.
    OpenUrlPubMed
  32. ↵
    1. De Kock M,
    2. Crochet B,
    3. Morimont C,
    4. Scholtes JL.
    (9, 1993) Intravenous or epidural clonidine for intra- and postoperative analgesia. Anesthesiology 79(3):525–531, pmid:8363078.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Castro MI,
    2. Eisenach JC.
    (9, 1989) Pharmacokinetics and dynamics of intravenous, intrathecal, and epidural clonidine in sheep. Anesthesiology 71(3):418–425, pmid:2774269.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Correa-Sales C,
    2. Rabin BC,
    3. Maze M.
    (6, 1992) A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology 76(6):948–952, pmid:1350889.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Collins JG,
    2. Kendig JJ,
    3. Mason P.
    (12, 1995) Anesthetic actions within the spinal cord: contributions to the state of general anesthesia. Trends Neurosci 18(12):549–553, pmid:8638296.
    OpenUrlCrossRefPubMed
  36. ↵
    1. De Kock M,
    2. Martin N,
    3. Scholtes JL.
    (9, 1992) Central effects of epidural and intravenous clonidine in patients anesthetized with enflurane/nitrous oxide. An electroencephalographic analysis. Anesthesiology 77(3):457–462, pmid:1519783.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Richards MJ,
    2. Skues MA,
    3. Jarvis AP,
    4. Prys-Roberts C.
    (8, 1990) Total i.v. anaesthesia with propofol and alfentanil: dose requirements for propofol and the effect of premedication with clonidine. Br J Anaesth 65(2):157–163, pmid:2223330.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Murga G,
    2. Samsó E,
    3. Valles J,
    4. Casanovas P,
    5. Puig MM.
    (11, 1994) The effect of clonidine on intra-operative requirements of fentanyl during combined epidural/general anaesthesia. Anaesthesia 49(11):999–1002, pmid:7802251.
    OpenUrlPubMed
  39. ↵
    1. Rostaing S,
    2. Bonnet F,
    3. Levron JC,
    4. Vodinh J,
    5. Pluskwa F,
    6. Saada M.
    (9, 1991) Effect of epidural clonidine on analgesia and pharmacokinetics of epidural fentanyl in postoperative patients. Anesthesiology 75(3):420–425, pmid:1888048.
    OpenUrlPubMed
  40. ↵
    1. Delaunay L,
    2. Leppert C,
    3. Dechaubry V,
    4. Levron JC,
    5. Liu N,
    6. Bonnet F.
    (May-Jun 1993) Epidural clonidine decreases postoperative requirements for epidural fentanyl. Reg Anesth 18(3):176–180, pmid:8323891.
    OpenUrlPubMed
  41. ↵
    1. Vercauteren M,
    2. Lauwers E,
    3. Meert T,
    4. De Hert S,
    5. Adriaensen H.
    (7, 1990) Comparison of epidural sufentanil plus clonidine with sufentanil alone for postoperative pain relief. Anaesthesia 45(7):531–534, pmid:2143638.
    OpenUrlCrossRefPubMed
  42. ↵
    1. Sullivan AF,
    2. Kalso EA,
    3. McQuay HJ,
    4. Dickenson AH.
    (5 11, 1992) Evidence for the involvement of the mu but not delta opioid receptor subtype in the synergistic interaction between opioid and alpha 2 adrenergic antinociception in the rat spinal cord. Neurosci Lett 139(1):65–68, pmid:1357605.
    OpenUrlCrossRefPubMed
  43. ↵
    1. Lee CC,
    2. Mok MS.
    (9, 1994) (1994) 1994 Annual Meeting Anesthesiology, Analgesic effect of epidural butorphanol and clonidine in combined use [abstract A946] (American Society of Anesthesiologists, San Francisco, CA) October 15-19, 81, (3A Suppl), p A947.
    OpenUrl
  44. ↵
    1. van Essen EJ,
    2. Bovill JG,
    3. Ploeger EJ,
    4. Schout BC.
    (1990) A comparison of epidural clonidine and morphine for postoperative analgesia. Eur J Anaesth 7(3):211–218.
    OpenUrl
  45. ↵
    1. Carabine UA,
    2. Milligan KR,
    3. Mulholland D,
    4. Moore J.
    (4, 1992) Extradural clonidine infusions for analgesia after total hip replacement. Br J Anaesth 68(4):338–343, pmid:1642909.
    OpenUrlCrossRefPubMed
  46. ↵
    1. Rockemann MG,
    2. Seeling W,
    3. Brinkmann A,
    4. et al.
    (5, 1995) Analgesic and hemodynamic effects of epidural clonidine, clonidine/morphine, and morphine after pancreatic surgery—a double-blind study. Anesth Analg 80(5):869–874, pmid:7726426.
    OpenUrlPubMed
  47. ↵
    1. Motsch J,
    2. Gräber E,
    3. Ludwig K.
    (12, 1990) Addition of clonidine enhances postoperative analgesia from epidural morphine: a double-blind study. Anesthesiology 73(6):1067–1073, pmid:2248385.
    OpenUrlPubMed
  48. ↵
    1. Carabine UA,
    2. Milligan KR,
    3. Moore J.
    (2, 1992) Extradural clonidine and bupivacaine for postoperative analgesia. Br J Anesth 68(2):132–135.
    OpenUrlCrossRefPubMed
  49. ↵
    1. Mogensen T,
    2. Eliasen K,
    3. Ejlersen E,
    4. Vegger P,
    5. Nielsen IK,
    6. Kehlet H.
    (10, 1992) Epidural clonidine enhances postoperative analgesia from a combined low-dose epidural bupivacaine and morphine regimen. Anesth Analg 75(4):607–610, pmid:1530174.
    OpenUrlPubMed
  50. ↵
    1. Bernard JM,
    2. Kick O,
    3. Bonnet F.
    (10, 1995) Comparison of intravenous and epidural clonidine for postoperative patient-controlled analgesia. Anesth Analg 81(4):706–712, pmid:7573998.
    OpenUrlCrossRefPubMed
  51. ↵
    1. De Kock M,
    2. Famenne F,
    3. Deckers G,
    4. Scholtes JL.
    (12, 1995) Epidural clonidine or sufentanil for intraoperative and postoperative analgesia. Anesth Analg 81(6):1154–1162, pmid:7486097.
    OpenUrlPubMed
  52. ↵
    1. Filos KS,
    2. Goudas LC,
    3. Patroni O,
    4. Polyzou V.
    (1993) First International Symposium on Alpha 2-Adrenergic Mechanisms of Spinal Anesthesia Reg Anesth, Dose-related hemodynamic and analgesic effects of intrathecal clonidine administered after cesarean section [abstract] (American Society of Regional Anesthesia, European Society of Regional Anesthesia), Jul-Aug, (suppl), 18, 4, p 18.
    OpenUrlPubMed
  53. ↵
    1. Penon C,
    2. Ecoffey C,
    3. Cohen SE.
    (6, 1991) Ventilatory response to carbon dioxide after epidural clonidine injection. Anesth Analg 72(6):761–764, pmid:1903615.
    OpenUrlPubMed
  54. ↵
    1. Rosa-e-Silva L,
    2. Troncon LE,
    3. Oliveira RB,
    4. Iazigi N,
    5. Gallo L Jr.,
    6. Foss MC.
    (4, 1995) Treatment of diabetic gastroparesis with oral clonidine. Aliment Pharmacol Ther 9(2):179–183, pmid:7605859.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords